Search

everythinglearnresearchcommunity

for

Search:↓

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

The free androgen index varies among women with different types of PCOS.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Certain gene variations and irregular X chromosome activity may contribute to hair loss in women who can have children.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Topical minoxidil 5% is the most effective over-the-counter treatment for male hair loss.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

People with X-linked hypohidrotic ectodermal dysplasia have no sweat ducts and less, thinner hair.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

A new mutation in the HR gene is linked to a rare form of hair loss with limb deformities.